This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2007 Sep;64(3):249-52.

doi: 10.1111/j.1365-2125.2007.03023.x.

Should we tolerate tolerability as an objective in early drug development?

A Cohen

PMID: 17716332
PMCID: PMC2000647
DOI: 10.1111/j.1365-2125.2007.03023.x

Editorial

Should we tolerate tolerability as an objective in early drug development?

A Cohen. Br J Clin Pharmacol. 2007 Sep.

. 2007 Sep;64(3):249-52.

doi: 10.1111/j.1365-2125.2007.03023.x.

Author

A Cohen

PMID: 17716332
PMCID: PMC2000647
DOI: 10.1111/j.1365-2125.2007.03023.x

No abstract available

PubMed Disclaimer

Similar articles

"Getting the dose right": facts, a blueprint, and encouragements.
Peck CC, Cross JT. Peck CC, et al. Clin Pharmacol Ther. 2007 Jul;82(1):12-4. doi: 10.1038/sj.clpt.6100215. Clin Pharmacol Ther. 2007. PMID: 17571068 No abstract available.
Historical development of pediatric pharmacology.
Seyberth HW, Rane A, Schwab M. Seyberth HW, et al. Handb Exp Pharmacol. 2011;205:v-vi. Handb Exp Pharmacol. 2011. PMID: 22046631 No abstract available.
Metabolites in safety testing: "MIST" for the clinical pharmacologist.
Frederick CB, Obach RS. Frederick CB, et al. Clin Pharmacol Ther. 2010 Mar;87(3):345-50. doi: 10.1038/clpt.2009.283. Epub 2010 Jan 27. Clin Pharmacol Ther. 2010. PMID: 20107437 Review. No abstract available.
Drug safety and the role of clinical pharmacology in the safe use of therapeutics.
Honig PK. Honig PK. Clin Pharmacol Ther. 2009 Mar;85(3):225-8. doi: 10.1038/clpt.2008.275. Clin Pharmacol Ther. 2009. PMID: 19223873 No abstract available.
Basic safety pharmacology: the cardiovascular system.
Lacroix P, Provost D. Lacroix P, et al. Therapie. 2000 Jan-Feb;55(1):63-9. Therapie. 2000. PMID: 10860003 Review.

See all similar articles

Cited by

Pharmacological vs. classical approaches in the design of first in man clinical drug trials.
van den Bogert CA, Cohen AF, Leufkens HGM, van Gerven JMA. van den Bogert CA, et al. Br J Clin Pharmacol. 2017 Dec;83(12):2807-2812. doi: 10.1111/bcp.13422. Epub 2017 Oct 6. Br J Clin Pharmacol. 2017. PMID: 28975652 Free PMC article.
Use of pharmacokinetic/ pharmacodynamic modelling for starting dose selection in first-in-human trials of high-risk biologics.
Agoram BM. Agoram BM. Br J Clin Pharmacol. 2009 Feb;67(2):153-60. doi: 10.1111/j.1365-2125.2008.03297.x. Epub 2008 Dec 11. Br J Clin Pharmacol. 2009. PMID: 19076987 Free PMC article.
Dose escalations in phase I studies: Feasibility of interpreting blinded pharmacodynamic data.
Hassing GJ, van Esdonk MJ, van Westen GJP, Cohen AF, Burggraaf J, Gal P. Hassing GJ, et al. Br J Clin Pharmacol. 2022 Dec;88(12):5412-5419. doi: 10.1111/bcp.15473. Epub 2022 Aug 12. Br J Clin Pharmacol. 2022. PMID: 35895751 Free PMC article.
A zwitterionic near-infrared fluorophore for real-time ureter identification during laparoscopic abdominopelvic surgery.
de Valk KS, Handgraaf HJ, Deken MM, Sibinga Mulder BG, Valentijn AR, Terwisscha van Scheltinga AG, Kuil J, van Esdonk MJ, Vuijk J, Bevers RF, Peeters KC, Holman FA, Frangioni JV, Burggraaf J, Vahrmeijer AL. de Valk KS, et al. Nat Commun. 2019 Jul 16;10(1):3118. doi: 10.1038/s41467-019-11014-1. Nat Commun. 2019. PMID: 31311922 Free PMC article. Clinical Trial.
Defining 'signal' and its subtypes in pharmacovigilance based on a systematic review of previous definitions.
Hauben M, Aronson JK. Hauben M, et al. Drug Saf. 2009;32(2):99-110. doi: 10.2165/00002018-200932020-00003. Drug Saf. 2009. PMID: 19236117

See all "Cited by" articles

References

1. Altman LK. Who goes first. The story of self experimentation in medicine. 1. Edition, New York: Random House; 1987. The case of the queasy chemists; pp. 86–105.
1. Goodyear M. Learning from the TGN1412 trial. BMJ. 2006;332:677–78. - PMC - PubMed
1. Kenter MJ, Cohen AF. Establishing risk of human experimentation with drugs: lessons from TGN1412. Lancet. 2006;368:1387–91. - PubMed
1. Altman LK. Who goes first. The story of self experimentation in medicine. 1. New York: Random House; 1987. The perilous route to painless surgery; pp. 53–85.
1. FDA. Note for Guidance on General Considerations for Clinical Trials. Federal Register. 62(242) 17-12-1997.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information